Picture of Cansino Biologics logo

6185 Cansino Biologics Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Momentum

Relative Strength (%)
1m-20.37%
3m-15.75%
6m-49.08%
1yr-75.08%
Volume Change (%)
10d/3m-46.34%
Price vs... (%)
52w High-81.21%
50d MA-17.73%
200d MA-49.45%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.55
PEG Ratio (f)n/a
EPS Growth (f)-31.85%
Dividend Yield (f)0.38%
Valuation (ttm)IndustryMarket
Price to Book Value1.73
Price to Tang. Book1.75
Price to Free Cashflow17.02
Price to Sales3.21
EV to EBITDA4.12

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital21.24%
Return on Equity27.22%
Operating Margin44.46%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Cansino Biologics EPS forecast chart

Profile Summary

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
January 13th, 2009
Public Since
March 28th, 2019
No. of Employees
1,946
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
264,174,099
Blurred out image of a map
Address
TIANJIN, 300457
Web
http://www.cansinotech.com.cn/
Phone
+86 2258213766
Auditors
Deloitte Touche Tohmatsu

6185 Share Price Performance

Upcoming Events for 6185

Similar to 6185

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ascletis Pharma logo

Ascletis Pharma

hk flag iconStock Exchange of Hong Kong Limited

Picture of Asymchem Laboratories Tianjin Co logo

Asymchem Laboratories Tianjin Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Guangzhou Baiyunshan Pharmaceutical Holdings Co logo

Guangzhou Baiyunshan Pharmaceutical Holdings Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Canbridge Pharmaceuticals logo

Canbridge Pharmaceuticals

hk flag iconStock Exchange of Hong Kong Limited

FAQ

Or unlock with your email

Or unlock with your email